Over the past decade, cell, apheresis and gene therapies have progressed from experimental concepts to established components of routine clinical care. What once appeared to be an ‘overnight success’ has been built on decades of scientific discovery, clinical translation and system-level innovation. For patients with otherwise refractory disease – and for the donors whose generosity underpins some of these therapies – the impact has been transformative.
Also of interest
-
Introducing our theme – Science at the heart of blood, transplantation and patient care
Professor Renata Gomes, Chief Scientific Officer of NHS Blood and Transplant, introduces our theme.
-
Advances in Transfusion Medicine Symposium 2024
This recent symposium, co-hosted by the Royal College of Pathologists (RCPath) and Serious Hazards of Transfusion (SHOT), brought together experts from various clinical disciplines with leaders in transfusion science to provide an update on key developments.